Advisors Preferred’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
BIT
BFA
Advisors Preferred's BIIB Position: Q3 2016 in Review
Advisors Preferred sold out of Biogen (BIIB) in Q3 2016, closing a stake of 101 shares — an estimated $24K sold.
Advisors Preferred first reported a position in BIIB in Q4 2013 and held it in 3 quarters. The position peaked at $63.9K in Q1 2014. 1,012 funds tracked by Wall St. Rank hold BIIB as of Q3 2016.
- Advisors Preferred reported no remaining Biogen position as of Q3 2016 after selling out during the quarter.
- Advisors Preferred sold 101 Biogen shares in Q3 2016, an estimated $24K.
- Advisors Preferred first reported a position in Biogen in Q4 2013 and held it in 3 quarters.
- Advisors Preferred's Biogen position peaked at $63.9K in Q1 2014.
- 1,012 funds tracked by Wall St. Rank held Biogen as of Q3 2016.
Based on Advisors Preferred's 13F filing for Q3 2016, filed 2 Nov 2016.